Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Retro Biosciences

Sam Altman–backed AI biotech announces $1 billion to extend human life span

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

Fortune · Jan 24, 2025

Sam Altman Net Worth 2024: Silicon Valley Visionary's Billion-Dollar Rise

Altman's official entry into the billionaire club in 2024 underscores his success in identifying and nurturing promising ventures.

International Business Times · Apr 3, 2024

OpenAI CEO's £142 Million Gamble On Unlocking the Secrets to Longer Life

A Silicon Valley startup bets on multiple anti-aging strategies (autophagy, cellular reprogramming, plasma therapy) for a longer lifespan.

International Business Times UK · Mar 25, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

British biotech races US’s ‘buff billionaires’ for secret of eternal youth

The UK excels at ‘longevity research’. Could it become part of an industry that fascinates the wealthiest people in the world?

The Guardian - UK · Nov 5, 2023

The rich are pouring millions into life extension research – but does it have any ethical value?

Sam Altman, the chief executive of OpenAI, recently invested US$180 million into Retro Biosciences – a company seeking to extend human lifespans by ten healthy years.

The Conversation · Apr 10, 2023

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.